N Alhussein, M Alosaimi, MK Alageel, SM Alwatban… - Cureus, 2023 - ncbi.nlm.nih.gov
Background The coronavirus type 2 that causes severe acute respiratory syndrome (SARS- CoV-2) was detected in December 2019 in Wuhan, China. A worldwide emergency …
S Izadmehr, DJ Lundon, N Mohamed, A Katims… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease–2019 (COVID-19), a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has become an unprecedented global …
K Glab-Ampai, K Kaewchim, T Saenlom… - International Journal of …, 2022 - mdpi.com
Broadly effective and safe anti-coronavirus agent is existentially needed. Major protease (3CLpro) is a highly conserved enzyme of betacoronaviruses. The enzyme plays pivotal role …
N Shukla, U Shamim, P Agarwal… - Briefings in …, 2023 - academic.oup.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) have been around for more than 3 years now. However, due to …
Manzamine-A is a marine-derived alkaloid which has anti-viral and anti-proliferative properties and is currently being investigated for its efficacy in the treatment of certain …
A Sukohar, Z Zetira - Medical Profession Journal of Lampung, 2020 - journalofmedula.com
The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has attracted the world's attention. On June the cases spreaded more than 200 countries and …
E Georgieva, Y Karamalakova, G Arabadzhiev… - Antioxidants, 2022 - mdpi.com
The main factors in the COVID-19 pathology, which can initiate extensive structural changes at the cellular and molecular levels, are the generation of free radicals in abnormal amounts …
R Dariolli, C Campana, A Gutierrez… - Frontiers in Physiology, 2021 - frontiersin.org
The rapid dissemination of SARS-CoV-2 has made COVID-19 a tremendous social, economic, and health burden. Despite the efforts to understand the virus and treat the …